Progressive multifocal leukoencephalopathy in patients treated with fumaric acid esters: a review of 19 cases

Concomitant granule cell neuronopathy in patients with natalizumab-associated PML

(2016) Martijn T. Wijburg et al.   JOURNAL OF NEUROLOGY

Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases

(2016) Roderick P. P. W. M. Maas et al.   JOURNAL OF NEUROLOGY

MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance

(2016) Martijn T Wijburg et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients

(2016) Mike P Wattjes et al.   Multiple Sclerosis Journal

Punctate pattern

(2016) Jérôme Hodel et al.   NEUROLOGY

PML during dimethyl fumarate treatment of multiple sclerosis: How does lymphopenia matter?

(2016) Klaus Lehmann-Horn et al.   NEUROLOGY

Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients

(2016) Mike P Wattjes et al.   Multiple Sclerosis Journal

Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate

(2015) Thorsten Bartsch et al.   ANNALS OF NEUROLOGY

Case report of a patient with progressive multifocal leukoencephalopathy under treatment with dimethyl fumarate

(2015) Nele Dammeier et al.   BMC Neurology

Dimethyl fumarate in relapsing–remitting multiple sclerosis: rationale, mechanisms of action, pharmacokinetics, efficacy and safety

(2015) Duvyanshu Dubey et al.   Expert Review of Neurotherapeutics

Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group

(2015) C McGuigan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS

(2015) Mike P Wattjes et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients

(2015) Erin E Longbrake et al.   Multiple Sclerosis Journal

MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients

(2015)   Nature Reviews Neurology

PML in a Patient without Severe Lymphocytopenia Receiving Dimethyl Fumarate

(2015) Dennis J. Nieuwkamp et al.   NEW ENGLAND JOURNAL OF MEDICINE

PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate

(2015) Thorsten Rosenkranz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dimethyl fumarate in relapsing–remitting multiple sclerosis: rationale, mechanisms of action, pharmacokinetics, efficacy and safety

(2015) Duvyanshu Dubey et al.   Expert Review of Neurotherapeutics

Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients

(2015) Erin E Longbrake et al.   Multiple Sclerosis Journal

Immune System Involvement in the Pathogenesis of JC Virus Induced PML: What is Learned from Studies of Patients with Underlying Diseases and Therapies as Risk Factors

(2015) Maria Chiara G. Monaco et al.   Frontiers in Immunology

Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro

(2015) Melanie S. Brennan et al.   PLoS One

Cerebellar manifestation of PML under fumarate and after efalizumab treatment of psoriasis

(2014) Muriel Stoppe et al.   JOURNAL OF NEUROLOGY

Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature

(2014) Martijn T. Wijburg et al.   JOURNAL OF NEUROLOGY

MRI pattern in asymptomatic natalizumab-associated PML

(2014) Mike P Wattjes et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Sorting out the risks in progressive multifocal leukoencephalopathy

(2014) Leonard H. Calabrese et al.   Nature Reviews Rheumatology

Outcome and survival of asymptomatic PML in natalizumab-treated MS patients

(2014) Tuan Dong-Si et al.   Annals of Clinical and Translational Neurology

The human JC polyomavirus (JCPyV): virological background and clinical implications

(2013) Hans H. Hirsch et al.   APMIS

Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era

(2013) J. L. Casado et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Oral BG-12 (dimethyl fumarate) for relapsing–remitting multiple sclerosis: a review of DEFINE and CONFIRM

(2013) Eva Havrdova et al.   EXPERT OPINION ON PHARMACOTHERAPY

PML diagnostic criteria: Consensus statement from the AAN Neuroinfectious Disease Section

(2013) J. R. Berger et al.   NEUROLOGY

PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy

(2013) Bob W. van Oosten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Manufacturer's Response to Case Reports of PML

(2013) Marianne T. Sweetser et al.   NEW ENGLAND JOURNAL OF MEDICINE

PML in a Patient Treated with Fumaric Acid

(2013) Ummehan Ermis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

(2012) Robert J. Fox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

(2012) Ralf Gold et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role of CD4+ and CD8+ T-Cell Responses against JC Virus in the Outcome of Patients with Progressive Multifocal Leukoencephalopathy (PML) and PML with Immune Reconstitution Inflammatory Syndrome

(2011) S. Gheuens et al.   JOURNAL OF VIROLOGY

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

(2010) David B Clifford et al.   LANCET NEUROLOGY

Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

(2010) Chen S Tan et al.   LANCET NEUROLOGY

Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis – A retrospective study (FUTURE)

(2009) Kristian Reich et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT